Engineers Gate Manager LP G1 Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $33,914 - $112,948	30,281 Added 210.9%	44,639 $136,000
Q3 2023 Nov 14, 2023	BUY	$1.22 - $2.67 $17,516 - $38,335	14,358 New	14,358 $20,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $104,786 - $272,565	20,190 Added 76.59%	46,551 $252,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $24,164 - $79,411	4,674 Added 21.55%	26,361 $329,000
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $87,615 - $184,556	21,687 New	21,687 $107,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $601,235 - $1.11 Million	-34,200 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$10.99 - $20.4 $154,926 - $287,578	-14,097 Reduced 29.19%	34,200 $615,000
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $557,830 - $1.15 Million	48,297 New	48,297 $558,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.